A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
Clinical trial NCT05070663 · COMPLETED
Trial details
- NCT number
- NCT05070663
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-04
- Primary completion
- 2024-03-14
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.